Home
DuoSpray

DuoSpray

DuoSpray: Bidose nasal spray platform for systemic intranasal drug delivery in acute therapies

DuoSpray is Nemera’s bidose nasal spray platform designed to support systemic intranasal drug delivery through a robust, patient-oriented and commercially ready device. Delivering two accurate metered doses within a single device, DuoSpray combines ease of use, industrial compatibility and development flexibility to support acute therapies. Developed for innovative drugs, repurposed molecules and generic products, DuoSpray helps pharmaceutical companies accelerate development while reducing regulatory, manufacturing and commercialization risks throughout the combination product journey.

DuoSpray: Bidose nasal spray platform for systemic intranasal drug delivery in acute therapies

Primeless and ready-to-use, DuoSpray features intuitive one-handed activation, a unique design, an integrated visual dose indicator and compatibility with industry-standard primary containers and conventional filling lines. Its flexible platform architecture enables seamless integration into pharmaceutical development programs while supporting efficient scale-up and commercialization.

As part of Nemera’s systemic intranasal delivery portfolio, DuoSpray complements UniSpray by providing an effective bidose solution for applications requiring two metered doses administrations

Ready-to-use, primeless bidose device
200 µL delivered as two 100 µL doses
Visual dose indicator
One-handed activation with 360° handling
Compatible with industry-standard primary containers and conventional filling lines

Designed for acute therapie
Accelerated time-to-marke
Reduced development risk
Suitable for innovative drugs, repurposed molecules and generics
Commercially ready platform

Combination Product Support Services

Thanks to our lab test capabilities, we can support specific generic projects through a complete set of tests that meets the authority’s prerequisite. This data generation will be statistically analyzed regarding USA and EU guidelines for eventual customers’ IVBE dossier registration filing.

A set of reliability testing and evaluation with customer’s formulation for a specific combination product, particularly for emergency treatments, required by FDA, leveraging our know-how to navigate regulatory landscape.lignment

Simulation to characterize a deposition profile of a specific formulation using nasal casts testing expertise for optimum administration efficacy for various therapeutic areas and targeted zones.